These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25456460)

  • 1. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment.
    Uher T; Benedict RH; Horakova D; Bergsland N; Dusankova JB; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    J Neurol Sci; 2014 Dec; 347(1-2):229-34. PubMed ID: 25456460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI correlates of disability progression in patients with CIS over 48 months.
    Uher T; Horakova D; Bergsland N; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    Neuroimage Clin; 2014; 6():312-9. PubMed ID: 25379444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray matter atrophy is associated with functional connectivity reorganization during the Paced Auditory Serial Addition Test (PASAT) execution in Multiple Sclerosis (MS).
    Baltruschat SA; Ventura-Campos N; Cruz-Gómez ÁJ; Belenguer A; Forn C
    J Neuroradiol; 2015 Jun; 42(3):141-9. PubMed ID: 25857687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.
    Maghzi AH; Revirajan N; Julian LJ; Spain R; Mowry EM; Liu S; Jin C; Green AJ; McCulloch CE; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2014 Nov; 3(6):720-7. PubMed ID: 25891551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    Patti F; De Stefano M; Lavorgna L; Messina S; Chisari CG; Ippolito D; Lanzillo R; Vacchiano V; Realmuto S; Valentino P; Coniglio G; Buccafusca M; Paolicelli D; D'Ambrosio A; Montella P; Brescia Morra V; Savettieri G; Alfano B; Gallo A; Simone I; Viterbo R; Zappia M; Bonavita S; Tedeschi G
    PLoS One; 2015; 10(3):e0120754. PubMed ID: 25816303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
    Rocca MA; Preziosa P; Mesaros S; Pagani E; Dackovic J; Stosic-Opincal T; Drulovic J; Filippi M
    Radiology; 2016 Mar; 278(3):841-53. PubMed ID: 26348234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.
    Uher T; Blahova-Dusankova J; Horakova D; Bergsland N; Tyblova M; Benedict RH; Kalincik T; Ramasamy DP; Seidl Z; Hagermeier J; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    J Neurol; 2014 Sep; 261(9):1735-44. PubMed ID: 24952618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R; Locatelli L; Cookfair D; Srinivasaraghavan B; Bertolotto A; Ukmar M; Bratina A; Maggiore C; Bosco A; Grop A; Catalan M; Zorzon M
    Mult Scler; 2007 May; 13(4):490-501. PubMed ID: 17463072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
    Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry.
    MacKenzie-Graham A; Brook J; Kurth F; Itoh Y; Meyer C; Montag MJ; Wang HJ; Elashoff R; Voskuhl RR
    Brain Behav; 2018 Sep; 8(9):e01086. PubMed ID: 30144306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
    Fisher E; Nakamura K; Lee JC; You X; Sperling B; Rudick RA
    Mult Scler; 2016 Apr; 22(5):668-76. PubMed ID: 26238463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
    Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.
    Pellicano C; Kane RL; Gallo A; Xiaobai L; Stern SK; Ikonomidou VN; Evangelou IE; Ohayon JM; Ehrmantraut M; Cantor FK; Bagnato F
    J Neuroimaging; 2013 Jul; 23(3):445-52. PubMed ID: 23227967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A; Damasceno BP; Cendes F
    Mult Scler Relat Disord; 2015 Mar; 4(2):137-43. PubMed ID: 25787189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.